Fulton Breakefield Broenniman LLC Charles River Laboratories International, Inc. Transaction History

Fulton Breakefield Broenniman LLC

  • $1.41 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 27, 2022
SELL
$255.51 - $362.11 $297,158 - $421,133
-1,163 Closed
0 $0
Q4 2021

Feb 07, 2022
SELL
$351.38 - $448.68 $22,136 - $28,266
-63 Reduced 5.14%
1,163 $438,000
Q3 2021

Oct 25, 2021
SELL
$372.64 - $458.3 $32,792 - $40,330
-88 Reduced 6.7%
1,226 $506,000
Q2 2021

Jul 27, 2021
BUY
$294.17 - $371.65 $386,539 - $488,348
1,314 New
1,314 $486,000

Others Institutions Holding CRL

# of Institutions
695
Shares Held
52.2M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.48B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Fulton Breakefield Broenniman LLC Portfolio

Follow Fulton Breakefield Broenniman LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Breakefield Broenniman LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulton Breakefield Broenniman LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email